James Hayward

James A. Hayward was the founder of Biocompatibles International Ltd., founded in 1984, where the title held was Research Director & Founding Principal from 1984 to 1989.
Dr. Hayward was the founder of Collaborative Group Ltd., founded in 1990, where the titles held were Chairman, President & Chief Executive Officer from 1990 to 2004.
Current jobs include Chief Executive Officer at LineaRx, Inc. starting in 2024; Chairman at Evotope Biosciences, Inc. since 2004; Director at Q-RNA, Inc. since 2001; Director at Softheon, Inc.; Director at The Research Foundation of The State University of New York; Director at Long Island Life Sciences Initiative; Director at Stony Brook Foundation, Inc.; Director at The Ward Melville Heritage Organization; Director at Long Island Angel Network, Inc.; Director at Form3 UK Ltd.; Director at Neomatrix Formulations, Inc.; Director at Tnpo2 Foundation; and General Partner at Double D Venture Fund since 2000.
Former jobs include Chairman, President & Chief Executive Officer at Engelhard Long Island, Inc. from 1990 to 2004; Chairman & Chief Executive Officer at BNB Plus Corp.
from 2024 to 2025; Director at New York Biotechnology Association, Inc.; and Head-Product Development at The Estée Lauder Companies, Inc. from 1984 to 1989.
Education includes an undergraduate degree from State University of New York College at Oneonta in 1976 and a doctorate from The State University of New York in 1983.